Documentation Centre

 

 

  of 663 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Endotoxin may not be the major cause of postprandial inflammation in adults who consume a single high-fat or moderately high-fat meal. J Nutr. 2020 May 1;150(5):1303-1312. August 11, 2020 Endotoxin may not be the major cause of postprandial inflammation in adults who consume a single high-fat or moderately high-fat meal. J Nutr. 2020 May 1;150(5):1303-1312. Mo Z, Huang S, Burnett DJ, Rutledge JC, Hwang DH Key Publications
High-risk atherosclerosis and metabolic phenotype: The roles of ectopic adiposity, atherogenic dyslipidemia, and inflammation. Metab Syndr Relat Disord. 2020 May;18(4):176-185. August 07, 2020 High-risk atherosclerosis and metabolic phenotype: The roles of ectopic adiposity, atherogenic dyslipidemia, and inflammation. Metab Syndr Relat Disord. 2020 May;18(4):176-185. Lechner K, McKenzie AL, Kränkel N, Von Schacky C, Worm N, Nixdorff U, Lechner B, Scherr J, Weingärtner O, Krauss RM Key Publications
Metabolic inflammation-a role for hepatic inflammatory pathways as drivers of comorbidities in nonalcoholic fatty liver disease? Gastroenterology. 2020;158:1929-1947. August 06, 2020 Metabolic inflammation-a role for hepatic inflammatory pathways as drivers of comorbidities in nonalcoholic fatty liver disease? Gastroenterology. 2020;158:1929-1947. Gehrke N, Schattenberg JM Key Publications
Inflammation in hypertension. Can J Cardiol. 2020;36:635-647. July 31, 2020 Inflammation in hypertension. Can J Cardiol. 2020;36:635-647. Xiao L, Harrison DG Key Publications
The impact of atherosclerotic risk factors on disease progression in patients with previously diagnosed nonobstructive coronary artery disease: factors affecting coronary artery disease progression. Coron Artery Dis. 2020;31:365-371. July 23, 2020 The impact of atherosclerotic risk factors on disease progression in patients with previously diagnosed nonobstructive coronary artery disease: factors affecting coronary artery disease progression. Coron Artery Dis. 2020;31:365-371. Durmaz E, Ikitimur B, Karadag B, Barman HA, Atici A, Koca D, Raimoglu U, Karaca OF, Mutlu D, Ongen Z Key Publications
Dr Peter Libby's Harvard laboratory. Eur Heart J. 2020;41:1225-1227 June 17, 2020 Dr Peter Libby's Harvard laboratory. Eur Heart J. 2020;41:1225-1227 European Heart Journal Key Publications
High-density lipoproteins are the main carriers of PCSK9 in the circulation. J Am Coll Cardiol. 2020;75:1495-1497 June 16, 2020 High-density lipoproteins are the main carriers of PCSK9 in the circulation. J Am Coll Cardiol. 2020;75:1495-1497 Burnap SA, Joshi A, Tsimikas S, Fernández-Hernando C, Kiechl S, Berry SE, Hall W, Levkau B, Mayr M Key Publications
Adiponectin and leptin in the diagnosis and therapy of NAFLD. Metabolism. 2020;103:154028 May 15, 2020 Adiponectin and leptin in the diagnosis and therapy of NAFLD. Metabolism. 2020;103:154028 Boutari C, Mantzoros CS Key Publications
The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study. Eur Heart J. 2019;40:3901-3909 April 27, 2020 The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study. Eur Heart J. 2019;40:3901-3909 Van't Klooster CC, Ridker PM, Hjortnaes J, van der Graaf Y, Asselbergs FW, Westerink J, Aerts JGJV, Visseren FLJ Key Publications
Inflammation, cardiovascular disease, and cancer: a common link with far-reaching implications. Eur Heart J. 2019;40:3910-3912 April 27, 2020 Inflammation, cardiovascular disease, and cancer: a common link with far-reaching implications. Eur Heart J. 2019;40:3910-3912 Lancellotti P, Marechal P, Donis N, Oury C Key Publications

  of 663 Next page

Go to page: of